In the rapidly evolving field of genomics, metagenomic sequencing has emerged as a powerful tool for studying genetic diversity in complex microbial communities. Understanding the statistics behind the metagenomic sequencing industry is essential for researchers, biotech companies, and healthcare professionals to make informed decisions and advancements in this cutting-edge field. In this blog post, we will delve into the key industry statistics shaping the future of metagenomic sequencing.
The Latest Metagenomic Sequencing Industry Statistics Explained
The metagenomic sequencing market is expected to register a CAGR of approximately 7.3% during the forecast period (2021-2026).
The statistic indicates that the metagenomic sequencing market is projected to experience a Compound Annual Growth Rate (CAGR) of approximately 7.3% over the period from 2021 to 2026. This growth rate suggests a steady and sustained increase in market value over the forecasted years, driven by factors such as advancements in sequencing technologies, increasing applications of metagenomics in various industries like healthcare and environmental monitoring, and rising demand for personalized medicine. The CAGR provides a useful measure for estimating the future performance and potential opportunities within the metagenomic sequencing market, revealing a positive outlook for the industry in terms of revenue growth and market expansion.
The rise in associated software solutions and increasing applications in agriculture are driving the demand for metagenomics sequencing.
This statistic indicates that the demand for metagenomics sequencing is on the rise in the field of agriculture due to the increasing use of associated software solutions and applications. Metagenomics sequencing refers to the study of genetic material directly taken from environmental samples, enabling researchers to analyze and identify microbial communities present in a given habitat. With advancements in technology and the development of various software tools tailored for agricultural purposes, metagenomics sequencing has become more accessible and valuable in understanding the complex microbial ecosystems in soils, plants, and animals. As a result, agricultural professionals are increasingly turning to metagenomics sequencing to enhance their understanding of these ecosystems and improve strategies for crop production, disease control, and soil health management.
North America dominates the metagenomics sequencing market due to advanced infrastructure and high spending on R&D.
The statistic suggests that North America is a leading region in the metagenomics sequencing market, largely due to its advanced infrastructure and significant investment in research and development (R&D) activities. The availability of cutting-edge technology, well-established research institutions, and a robust funding system in North America likely contribute to the region’s dominant position in metagenomics sequencing. This implies that North American companies and research organizations may have a competitive advantage when it comes to developing and implementing innovative metagenomics sequencing techniques and technologies, thus shaping the market landscape in their favor.
The Asia Pacific region is expected to be the fastest-growing region in the global metagenomic sequencing market.
The statistic indicates that the Asia Pacific region is projected to experience the most rapid growth compared to other regions in the global metagenomic sequencing market. This growth is attributed to various factors such as increasing investments in healthcare research and development, advancements in technology, rising prevalence of infectious diseases, and expanding government initiatives to promote genomics research in countries across the region. As a result, the Asia Pacific region is likely to witness significant expansion in the adoption of metagenomic sequencing technologies, which can offer insights into microbial communities and their functions, thus driving growth in applications such as infectious disease surveillance, environmental monitoring, and precision medicine.
The global metagenomics market size was valued at USD 417.1 million in 2018.
The statistic ‘The global metagenomics market size was valued at USD 417.1 million in 2018’ indicates the total market value of metagenomics products and services worldwide in the year 2018. Metagenomics is a field of study that involves the genetic analysis of microbial communities found in environmental samples. The market size represents the total revenue generated by companies offering metagenomics-related products and services such as sequencing technologies, bioinformatics tools, and research services. This figure serves as a key indicator of the growth and importance of metagenomics in scientific research, healthcare, agriculture, and other industries, highlighting the increasing demand and investment in this field.
The global metagenomics market size is expected to reach USD 1.07 billion by 2025.
The statistic “The global metagenomics market size is expected to reach USD 1.07 billion by 2025” indicates the projected total value of the metagenomics market worldwide by the year 2025. Metagenomics is the study of genetic material recovered directly from environmental samples and has applications in various sectors such as healthcare, agriculture, environmental monitoring, and biotechnology. The projected market size of USD 1.07 billion reflects the anticipated growth and increasing demand for metagenomics technologies and services globally, driven by advancements in genomic technologies, rising investments in research and development, and growing awareness of the potential applications of metagenomics in diverse industries.
The metagenomics market is expected to have a CAGR of 15.4% from 2019 to 2025.
The statistic stating that the metagenomics market is expected to have a compound annual growth rate (CAGR) of 15.4% from 2019 to 2025 signifies the anticipated average yearly expansion rate of the market over that period. This indicates a strong projected growth trajectory for the industry, implying that by 2025, the market is expected to be significantly larger than its current size in 2019. The CAGR serves as a valuable metric for understanding the steady annual growth rate of a market or industry, providing insights into future trends and opportunities for investors, businesses, and other stakeholders operating within the metagenomics sector.
Bioinformatics-based services accounted for the largest revenue share in terms of technology in 2018, due to its high penetration in the market.
The statistic indicates that in 2018, bioinformatics-based services generated the highest revenue compared to other technologies in the industry. This was attributed to the widespread adoption and utilization of bioinformatics tools and services within the market. Bioinformatics, which involves the application of computational techniques to analyze biological data, has seen significant growth and acceptance across various sectors such as research, pharmaceuticals, agriculture, and healthcare. Its ability to streamline data analysis, identify patterns, and drive insights has made it a critical component in decision-making processes, leading to its dominant revenue share within the technology sector in 2018.
Shotgun sequencing is projected to witness the fastest CAGR of 16.5% from 2019 to 2025.
The statistic states that shotgun sequencing, a method used in genomics to sequence DNA rapidly and cost-effectively, is expected to experience the fastest Compound Annual Growth Rate (CAGR) of 16.5% between the years 2019 and 2025. This projection suggests significant growth in the adoption and utilization of shotgun sequencing technology over the specified period. The high CAGR indicates a strong market demand for this sequencing method, likely driven by advancements in genomic research, biotechnology innovations, and the need for efficient and scalable DNA sequencing solutions across various industries such as healthcare, agriculture, and environmental sciences.
North America led the market in 2018, due to the high presence of key players and a supportive funding scenario.
The statistic “North America led the market in 2018, due to the high presence of key players and a supportive funding scenario” suggests that North America outperformed other regions in terms of market leadership during the year 2018. This can be attributed to the strong presence of major companies in the region, indicating a competitive advantage in terms of market share and influence. Additionally, the supportive funding scenario in North America likely played a crucial role in driving growth and innovation within the market, offering financial resources and opportunities for businesses to thrive. Overall, North America’s leading position in 2018 can be linked to a combination of industry expertise, strategic investments, and favorable economic conditions within the region.
The Asia Pacific region is expected to be the fastest-growing region over the forecast period (2019-2025).
The statement indicates that the Asia Pacific region is projected to experience the highest rate of economic growth compared to other regions from 2019 to 2025. This forecast suggests that countries within the Asia Pacific region are expected to demonstrate significant advancement in areas such as gross domestic product (GDP), industrial output, consumer spending, and other economic indicators. Factors such as population growth, increasing urbanization, rising incomes, and expanding markets contribute to the region’s strong economic performance. This projection highlights the potential opportunities for businesses and investors in the Asia Pacific region during the specified period.
In 2017, the global market for metagenomic sequencing was valued at about $817.6 million.
The statistic stating that in 2017 the global market for metagenomic sequencing was valued at approximately $817.6 million represents the monetary worth of the industry focused on analyzing genetic material from environmental samples. Metagenomic sequencing is a cutting-edge technique that allows scientists to study complex microbial communities present in various habitats, providing insights into microbial diversity, function, and evolution. The significant market value indicates the growing interest and investment in metagenomics research, with potential applications in fields such as biotechnology, medicine, environmental science, and agriculture. This statistic reflects the expanding opportunities and potential impact of metagenomic sequencing in advancing our understanding of microbial ecosystems and their role in diverse biological processes.
The global metagenomics sequencing market is estimated to reach $2,221.9 million by 2026.
This statistic indicates that the global metagenomics sequencing market is projected to grow significantly over the coming years, with an estimated value of $2,221.9 million by the year 2026. Metagenomics sequencing involves studying the genetic material collected from environmental samples, such as soil or water, to understand the microbial communities present. The increasing demand for metagenomics sequencing services and technologies, driven by applications in areas such as microbiome research, environmental monitoring, and healthcare, is expected to fuel this market growth. Factors such as technological advancements, expanding research activities, and rising investments in genomics research are likely to contribute to the rapid expansion of the metagenomics sequencing market.
The global metagenomics market is projected to reach $314 million by 2024 from $165 million in 2018, at a CAGR of 14.0%.
The statistic indicates that the global metagenomics market, which was valued at $165 million in 2018, is expected to increase significantly to $314 million by the year 2024, representing a Compound Annual Growth Rate (CAGR) of 14.0%. This suggests a robust and steady growth trend in the metagenomics market over the forecast period. The growth is fueled by factors such as increasing research and development activities in the field of metagenomics, growing awareness about personalized medicine, and the rising demand for efficient and advanced molecular diagnostic techniques. This projected growth reflects the expanding applications and adoption of metagenomics technologies across various industries such as healthcare, environmental monitoring, and agriculture.
The shotgun metagenomic sequencing segment is expected to grow at the highest CAGR during the forecast period (2018-2024).
The statistic highlights that within the field of metagenomic sequencing, the shotgun sequencing approach is projected to experience the highest Compound Annual Growth Rate (CAGR) during the forecast period from 2018 to 2024. Shotgun metagenomic sequencing involves randomly sequencing DNA fragments from an environmental sample, allowing for a comprehensive analysis of the genetic material present. The high expected growth rate suggests that researchers and industries are increasingly recognizing the value and potential applications of shotgun metagenomic sequencing in various fields such as microbiology, environmental science, and personalized medicine. This growth could be driven by advancements in sequencing technologies, decreasing costs of sequencing, and expanding research interests in understanding complex microbial communities.
The academic institutes segment held the largest share of the global metagenomics sequencing market in 2017.
The statistic indicates that in the year 2017, academic institutes accounted for the highest proportion of market share within the global metagenomics sequencing market. This implies that academic institutions, such as research universities and educational organizations, were the leading contributors to activities involving metagenomics sequencing during that period. The dominance of academic institutes in this market segment highlights their significant role in advancing research and innovation within the field of metagenomics, indicating a strong presence and influence of academic research in driving developments and discoveries in this area of study.
Asia Pacific is expected to be a highly lucrative market for metagenomics and it is expected to expand at a high CAGR during the forecast period.
This statistic suggests that the Asia Pacific region is predicted to be a very profitable market for metagenomics, a rapidly growing field that involves studying genetic material from environmental samples. The statement indicates that there is strong potential for significant growth, as evidenced by the expected high Compound Annual Growth Rate (CAGR) during the forecast period. This forecast likely takes into account various factors such as increasing investments in research and development, growing awareness and adoption of metagenomics technologies, and expanding collaborations within the region. Overall, it highlights the promising opportunities and potential economic benefits that the Asia Pacific market holds for the metagenomics industry in the coming years.
The market for Clinical Diagnostic and applications is expected to grow at a CAGR of 12% during the forecast period (2021-2026).
This statistic indicates that the market for Clinical Diagnostic and applications is projected to experience a Compound Annual Growth Rate (CAGR) of 12% over the period from 2021 to 2026. This suggests a strong and steady growth rate for the market sector, potentially driven by factors such as technological advancements, increasing demand for diagnostic services, and expanding healthcare infrastructure. A 12% CAGR implies that the market is expected to more than double in size by the end of the forecast period, reflecting significant opportunities and potential for investment and expansion within the Clinical Diagnostic industry.
The infectious disease application segment held the largest revenue share in 2020, accounting for over 30% of the total market.
The statistic indicates that in 2020, the infectious disease application segment generated the most revenue among all the segments in the market, contributing over 30% to the total revenue of the industry. This suggests that products, services, or technologies related to combating infectious diseases were in high demand and were driving significant revenue for the market. The prominence of the infectious disease application segment highlights the crucial role they play in the market landscape, possibly due to factors such as the global pandemic and the increasing focus on public health and disease prevention. This statistic underscores the importance of addressing infectious diseases in the healthcare industry and reflects a significant portion of the market share held by this specific application segment in 2020.
The bioinformatics segment held a dominant share in the market in 2020 and it is expected to maintain its dominance during the forecast period.
The statistic indicates that the bioinformatics segment had a significant market share in 2020 and is projected to continue leading the market in the future. This suggests that the fields of biology and information technology combined to analyze and interpret complex biological data were in high demand and proved to be highly valuable in various industries. The dominance of the bioinformatics segment is expected to persist due to the increasing reliance on advanced technology and data-driven decision-making processes, highlighting the importance of bioinformatics tools and services in driving innovation and progress in related industries.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.grandviewresearch.com
2. – https://www.www.transparencymarketresearch.com
3. – https://www.www.marketsandmarkets.com
